IS FERRITIN A GOOD PREDICTOR OF SURVIVAL ACROSS ALL RISK LEVELS IN MYELODYSPLASTIC NEOPLASMS? INSIGHTS FROM A STRATIFIED COHORT STUDY

Autor: Passos, PRC, Dias, RDB, Carneiro, SCC, Nogueira, IB, Venâncio, RC, Gama, JVG, Lima, JMGF, Lavor, ACG, Pinheiro, RF, Magalhães, SMM
Zdroj: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S446-S446
Databáze: ScienceDirect